HAIFA, Israel, Sept. 11 /PRNewswire/ -- Elscint Ltd. (NYSE: ELT), a
subsidiary of Elbit Medical Imaging Ltd. (Nasdaq: EMITF), announced today that
Jonathan Adereth and Dan Inbar have resigned as directors of Elscint.
Mr. Adereth was, until last month, the President and Chief Executive
Officer of Elscint.
Emmanuel Gill, Chairman and Chief Executive Officer of Elscint, and all of
the members of the Company's Board expressed their regret over Mr. Adereth's
and Mr. Inbar's decision to resign and are grateful to both of them for their
contribution to Elscint and their participation in the Board's deliberations
during their tenure.
Elscint is an advanced medical imaging company serving healthcare
professionals worldwide. Guided by the philosophy of applying unique
technologies for the advancement of cost-effective healthcare, Elscint
designs, manufactures, sells and services a wide range of sophisticated
computer-based medical imaging products including Computerized Tomography
(CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine (NM) and Mammography
systems.
internet home page: http://www.elscint.co.il
SOURCE Elscint Ltd.
 back to top
Related links:
http://www.elscint.co.il
CONTACT:
Emmanuel Gill, Chairman of the Board of
Elscint Ltd., 972-4-8550219; or Laurie Berman, General Info.,
310-442-0599, Alicia Nieva-Woodgate, Media Info., 415-986-1591,
or Brian Gill, Investor Info., 212-661-8030, all of The Financial
Relations Board
NOTE TO EDITORS: For further information on Elscint, via
facsimile at no cost, please call 1-800-PRO-INFO and enter
company code 206 or ticker symbol ELT
|
